Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03135119 · ClinicalTrials.gov registry record · NA
Integrating Animal-Assisted Therapy Into Trauma-Focused Cognitive-Behavioral Therapy for Maltreated Youth
A NA study of Child Abuse and Post-traumatic Stress, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
- 1
- Study location
NCT03135119: Completed NA study of Child Abuse and Post-traumatic Stress, sponsored by Milton S. Hershey Medical Center.
NCT03135119 is a NA study of Child Abuse and Post-traumatic Stress that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 33 participants, below the 3,312-participant average among 19 other Child Abuse trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03135119, a NA study of Child Abuse and Post-traumatic Stress, has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will examine the incremental benefit of animal-assisted therapy (AAT) as an adjunct intervention when combined with Trauma-Focused Cognitive-Behavioral Therapy (TF-CBT) for the treatment of maltreated youth. In addition, the development of therapeutic rapport and the intensity of stress experienced during treatment sessions will be examined as mediational mechanisms of treatment outcome. This project will help determine whether a larger study to test the beneficial effects of AAT for maltreated youth is feasible and warranted.
Primary Outcome
This is a caregiver version of the measure designed to assess child/youth posttraumatic stress disorder (PTSD) symptoms. This is a 27-item questionnaire were the frequency of each item is reported using a scale ranging from 0 (Never) to 4 (Most Days), yielding a potential full scale score ranging from 0 to 108. For inclusion in this study, a score of at least 32 on the pre-treatment administration was required as this score denotes the "borderline" range for the measure. Lower scores indicate fe
Conditions Studied
Interventions
- BEHAVIORAL TF-CBT
- BEHAVIORAL TF-CBT+AAT
Study Locations (1)
Pennsylvania
- Penn State Hershey Medical Center-TLC Research and Treatment Center - Harrisburg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2017-11-15 |
| Est. Completion | 2020-03-18 |
| Phase | NA |
What the finished NCT03135119 record still lists
NCT03135119 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 33 participants, a relatively small participant target, below the 3,312-participant average among 19 other Child Abuse trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Child Abuse appearing as the primary indexed condition, and to 2 interventions - of which TF-CBT is the first listed.
NCT03135119 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03135119 about?
NCT03135119 is a clinical study titled "Integrating Animal-Assisted Therapy Into Trauma-Focused Cognitive-Behavioral Therapy for Maltreated Youth". This study will examine the incremental benefit of animal-assisted therapy (AAT) as an adjunct intervention when combined with Trauma-Focused Cognitive-Behavioral Therapy (TF-CBT) for the treatment of maltreated youth. In addition, the development of therapeutic rapport and the intensity of stress e...
What is the current status of trial NCT03135119?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2017-11-15. Estimated completion is 2020-03-18.
What conditions does trial NCT03135119 study?
This clinical trial studies the following conditions: Child Abuse, Post-traumatic Stress.
What interventions are being tested in trial NCT03135119?
The interventions under investigation include: TF-CBT (BEHAVIORAL), TF-CBT+AAT (BEHAVIORAL).
Who is sponsoring clinical trial NCT03135119?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03135119 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Child Abuse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03135119's enrollment target sits among peer trials
33 20th of 19 the lowest of 19 other Child Abuse trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Child Abuse trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
K-ORCA: Testing a Decision Support Tool and Group Process for Selecting Interventions
RECRUITING · NA
-
iLookOut for Child Abuse -Online Learning Module for Early Childcare Providers
RECRUITING · NA
-
A Regional Partnership to Improve Outcomes Through Fatherhood Engagement
RECRUITING · NA
-
iLookOut for Child Abuse: Micro-learning to Improve Knowledge Retention
RECRUITING · NA
-
Catholic Health Initiatives (CHI) St. Joseph's Children Home Visiting Longitudinal Study
ACTIVE NOT RECRUITING · NA
-
Fostering Healthy Futures for Teens: An RCT
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02861898 · 33 participants · Phase 1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- NCT04871607 · 33 participants · Phase 2
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
- NCT05071937 · 33 participants · Phase 2
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- NCT05168618 · 33 participants · Phase 2
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI